000			01169 a2200337 4500
005			20250513183056.0
264		0	_c19990701
008			199907s 0 0 eng d
022			_a1081-0943
040			_aNLM _beng _cNLM
100	1		_aNelson, M A
245	0	0	_aSelenium and prostate cancer prevention. _h[electronic resource]
260			_bSeminars in urologic oncology _cMay 1999
300			_a91-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aCell Division _xdrug effects
650	0	4	_aChemoprevention
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPrimary Prevention _xmethods
650	0	4	_aProstatic Neoplasms _xepidemiology
650	0	4	_aRisk Factors
650	0	4	_aSelenium _xchemistry
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aPorterfield, B W
700	1		_aJacobs, E T
700	1		_aClark, L C
773	0		_tSeminars in urologic oncology _gvol. 17 _gno. 2 _gp. 91-6
999			_c10291746 _d10291746